enGene Therapeutics, Inc. (ENGN)

1.81 +0.03 (+1.69%) USD  |  NASDAQ  |  Aug 24, 16:00
1.82 +0.01 (+0.55%) After-Hours: 20:00
More

enGene Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for ENGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to . Start Trial.
Date Value

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Aurinia Pharmaceuticals, Inc. Upgrade
Medicus Pharma Ltd. --
Sirona Biochem Corp. --
Xenon Pharmaceuticals, Inc. Upgrade
Psyence Biomedical Ltd. --